SELLAS Life Sciences Group, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-23.8M | $-17.7M | $-63.9M | $-36.6M | $-76.7M | $-35.0M | $-11.5M | $-12.0M |
| Depreciation & Amortization | — | $3.0K | $107.0K | $86.0K | $286.0K | $49.0K | $163.0K | $172.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.9M | — | — | $440.0K | $131.0K | — | — | — |
| Stock-Based Compensation | $3.2M | $354.0K | $1.9M | $4.7M | $2.3M | $1.4M | $3.0M | $4.4M |
| Net Cash from Operating Activities | $-11.0M | $-11.9M | $-48.2M | $-42.9M | $-28.9M | $-21.0M | $-14.7M | $-10.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $6.0K | $153.0K | $57.0K | $320.0K | — | $53.0K | $106.0K |
| Business Acquisitions | — | $0 | $0 | $0 | $15.1M | $0 | — | — |
| Net Cash from Investing Activities | $12.2M | $-85.0K | $10.4M | $-5.5M | $-12.0M | $-87.0K | $14.0K | $-106.0K |
| Financing Activities | ||||||||
| Dividends Paid | $0 | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | $3.8M |
| Net Cash from Financing Activities | $5.5M | $16.5M | $43.8M | $24.3M | $55.9M | $42.4M | $19.2M | $11.6M |
| Net Change in Cash | $-3.6M | $4.6M | $6.1M | $-24.1M | $15.0M | $21.4M | $4.5M | $1.2M |
| Free Cash Flow | — | $-11.9M | $-48.3M | $-42.9M | $-29.2M | — | $-14.7M | $-10.4M |